Reuters logo
BRIEF-Novartis says CAR-T cell therapy unanimously recommended for approval by FDA advisory committee
July 13, 2017 / 1:15 AM / 4 months ago

BRIEF-Novartis says CAR-T cell therapy unanimously recommended for approval by FDA advisory committee

July 12 (Reuters) - Novartis Ag -

* Novartis CAR-T cell therapy CTl019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL

* Effective treatment options for patients with r/r ALL are limited

* Company plans additional filings for CTl019 in U.S. and European Union later this year, including applications with FDA and European medicines agency

* Biologics license application for this indication is under FDA priority review Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below